Brugada Ablation of VF Substrate Ongoing MultiCenter Registry
Sponsored by Pacific Rim Electrophysiology Research Institute
About this trial
Last updated 2 years ago
Study ID
BRAVO Registry
Status
Completed
Type
Observational
Placebo
No
Accepting
18 to 80 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 3 years ago
What is this trial about?
Current treatment of high-risk Brugada Syndrome (BrS) patients (pts) with recurrent VF is
limited. Catheter ablation (CA) has been performed for BrS but a large study with long-term
outcomes of CA in BrS ablation are lacking.
What are the participation requirements?
Inclusion Criteria
- Symptomatic Brugada Syndrome patients who had undergone catheter ablation of the arrhythmogenic substrates.
Exclusion Criteria
- Patients who will not commit to regular follow up.